Loading people...
Harlan Krumholz is a Venture Partner at F-Prime Capital Partners, a global venture capital firm. He plays a key role in identifying and supporting innovative companies, primarily in the healthcare and technology sectors.
Harlan Krumholz focuses his investments on groundbreaking companies within the healthcare and technology sectors. This includes areas like digital health, biotech, medical devices, fintech, enterprise software, and artificial intelligence, aligning with F-Prime Capital Partners' strategic focus.
Harlan Krumholz works as a Venture Partner at F-Prime Capital Partners, a prominent global venture capital firm.
Harlan Krumholz is a Venture Partner at F-Prime Capital Partners and the Harold H. Hines, Jr. Professor of Medicine at Yale University, based in New Haven, Connecticut. Since joining the venture firm in August 2020, he has focused on healthcare innovation while simultaneously serving as the Director of the Center for Outcomes Research and Evaluation at Yale New Haven Hospital. As an entrepreneur and clinical researcher, he founded the patient-mediated health data platform Hugo Health and has authored over 1,000 scientific publications, achieving an h-index exceeding 200. He earned his medical degree from Harvard Medical School and developed specific hospital quality measures currently utilized nationally by the Centers for Medicare & Medicaid Services. His current professional focus centers on advancing digital health, cardiovascular medicine, and patient-centric data platforms to improve clinical outcomes and care delivery.
Harlan Krumholz is a distinguished Venture Partner at F-Prime Capital Partners, a leading global venture capital firm renowned for its strategic investments in technology and healthcare. In his pivotal role, Harlan contributes significantly to F-Prime's mission of identifying, nurturing, and scaling innovative companies that are poised to disrupt their respective industries. His work involves a deep dive into emerging market trends, rigorous due diligence, and providing invaluable strategic guidance to portfolio companies.
At F-Prime Capital Partners, Harlan's investment focus areas are broad yet targeted, typically aligning with the firm's core sectors. These often include cutting-edge healthcare solutions, such as digital health, biotech, and medical devices, as well as transformative technologies spanning fintech, enterprise software, and artificial intelligence. He is particularly interested in ventures that demonstrate strong intellectual property, scalable business models, and a clear path to market leadership, seeking out founders with compelling visions and the drive to execute.
While specific details of Harlan Krumholz's extensive career background are not publicly detailed, a Venture Partner at a firm like F-Prime typically brings a wealth of operational experience, entrepreneurial success, or deep domain expertise from relevant industries. This background likely includes leadership roles in successful startups, significant contributions to established technology or healthcare enterprises, or a strong track record in academic research and innovation. Such a foundation equips him with the practical insights necessary to guide early-stage companies through their growth trajectories, from product development to market penetration and beyond.
F-Prime Capital Partners boasts a robust portfolio of successful companies across its investment sectors. While specific notable investments directly attributed to Harlan Krumholz are not widely publicized, his contributions as a Venture Partner are integral to the firm's overall success in identifying and supporting these high-potential ventures. He plays a crucial role in leveraging F-Prime's extensive network and resources to help portfolio companies achieve their strategic objectives, fostering innovation and driving significant returns. Harlan Krumholz embodies F-Prime's commitment to partnering with exceptional entrepreneurs to build the next generation of industry leaders.
